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Subcellular localization is an important aspect of protein function, but the protein composition
of many intracellular compartments is poorly characterized. For example, many nuclear bodies
are challenging to isolate biochemically and thus remain inaccessible to proteomics. Here,
we explore covariation in proteomics data as an alternative route to subcellular proteomes.
Rather than targeting a structure of interest biochemically, we target it by machine learning.
This becomes possible by taking data obtained for one organelle and searching it for traces
of another organelle. As an extreme example and proof-of-concept we predict mitochondrial
proteins based on their covariation in published interphase chromatin data. We detect about⅓
of the knownmitochondrial proteins in our chromatin data, presumablymost as contaminants.
However, these proteins are not present at random. We show covariation of mitochondrial
proteins in chromatin proteomics data. We then exploit this covariation by multiclassifier
combinatorial proteomics to define a list of mitochondrial proteins. This list agrees well with
different databases on mitochondrial composition. This benchmark test raises the possibility
that, in principle, covariation proteomics may also be applicable to structures for which no
biochemical isolation procedures are available.
Keywords:
Chromatin / Machine learning / Mitochondria / Organelle / Systems biology
 Additional supporting information may be found in the online version of this article atthe publisher’s web-site
1 Introduction
Eukaryotic cells contain organelles and other specialized
compartments, whose protein composition can be analyzed
by proteomics to provide important clues regarding their
biological function [1, 2]. Organelle proteomics approaches
traditionally depend on the biochemical isolation of the
analyzed structure, which can be relatively straightforward
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for membrane-enclosed organelles such as mitochondria [3].
However, the majority of spatial compartments cannot be
adequately enriched for conclusive analysis, as their isolates
may be contaminated with too many functionally unrelated
proteins that copurify. Alternative approaches have therefore
been developed to infer the composition of organelles that
cannot be purified to homogeneity. For example, subtractive
[4] and quantitative [5] proteomics approaches have been
employed to distinguish between genuine components and
contaminants in biochemical isolates of nuclear envelopes
and lipid rafts, respectively. Partial enrichment combined
with quantitative proteomic analysis was used to broadly cate-
gorize the cell into cytoplasm, nucleus, and nucleolus [6]. Pro-
tein correlation profiling was developed to study the compo-
sition of the centrosome [7] and later provided a mammalian
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Significance of the study
This study introduces a new concept for organelle pro-
teomics. Until now, specific biochemical enrichment was
paramount to study biological structures by proteomics.
However, many compartments in the cell simply cannot
be isolated or even partially separated from the rest of the
cell. Examples for this include chromatin, which is highly
charged and invariably “absorbs” functionally unrelated pro-
teins, and nuclear bodies that are not surrounded by a mem-
brane andmost likely disintegrate upon cell lysis.We present
here a method that may overcome such challenges in the fu-
ture. The basic idea is that machine-learning can identify
organelle-specific patterns across many comparative pro-
teomics studies, even if the organelle was just present as
contamination in the original experiment. As a proof-of-
principle we identified mitochondrial proteins from chro-
matin proteomics data. While we do not have enough data at
the moment to define the entire mitochondrial proteome in
this way, our experiment shows that enriching an organelle
through biochemical fractionation is no longer a strict re-
quirement to analyze its composition. We envisage that this
method may be useful to study a multitude of nonpurifiable
biological structures in the future.
organelle map [8]. Using a related method, localization of
organelle proteins by isotope tagging, proteins were assigned
to the various compartments of the endomembrane system,
which cannot be efficiently distinguished biochemically
[9].
When analyzing mitotic chromosomes we also encoun-
tered an abundant presence of background proteins [10]. Im-
portantly,mitotic chromosomes are large and highly charged,
attracting many functionally unrelated proteins, and thus are
physically contaminated themselves. This made it difficult to
identify contaminants using the existing fractionation-based
procedures. We therefore proposed a machine learning ap-
proach, multiclassifier combinatorial proteomics (MCCP), as
a solution. Taking the outcome of multiple proteomic analy-
ses of mitotic chromosomes that were done under biochemi-
cally or genetically distinct conditions, and integrating those
by Random Forest analysis provided a ranked list of protein
components of mitotic chromosomes. Interphase chromatin
is another example of a specialized functional compartment
whose biochemical isolates remain highly impure [11]. Work-
ingwithpartially purifiedmaterial, weusedMCCP to infer the
protein composition of interphase chromatin from biological
covariation. For this we analyzed chromatin-enriched sam-
ples from a wide variety of biological conditions and showed
that proteins with well-known chromatin functions tend to
respond in a similar way to various perturbations, such as
drug treatments. We subsequently used a machine learning
algorithm to capture the covariation pattern corresponding
to chromatin factors. The resulting model allowed us to pre-
dict hundreds of new potential interphase chromatin proteins
simply based on their covariation with already known chro-
matin proteins.
Some compartments may be inherently unstable in vitro.
For example, it has been proposed that many intracellular
bodies represent liquid droplets that form by phase transi-
tion from the surrounding cyto- or nucleoplasm [12]. Such
compartments may be very difficult or even impossible to pu-
rify biochemically, and presumablywould start to disintegrate
after cell lysis. Therefore, new approaches may be required
to determine their protein composition. Possibly, also here a
solution could come from machine learning.
One conclusion from our analysis of interphase chromatin
was that covariation with reference proteins was more accu-
rate than biochemical enrichment in identifying chromatin
components. This raised the intriguing possibility that bio-
chemical enrichment may not be an essential element of
determining the composition of cellular structures by pro-
teomics. To push this hypothesis to its extreme we wondered
if an entirely untargeted organelle could be defined through
its changing coappearance in the analysis of chromatin. This
would offer a way to study the composition of nonpurifiable
compartments, especially that of many elusive nuclear bodies
that may stick to chromatin when it is isolated but that cannot
be isolated on their own.
To test the hypothesis that covariation in proteomic
datasets can be the central element of studying the composi-
tion of cellular structures by proteomics, we attempted to de-
fine the composition ofmitochondria on the basis of our chro-
matin proteomics dataset. Our intention was not to present
an alternative or even superior way of analyzing mitochon-
dria but simply to use mitochondria as a test system for other
organelles or structures that challenge current analysis ap-
proaches. Mitochondria are large, well defined, and not func-
tionally linked to chromatin in any obvious way, but are fre-
quently part of the background of our chromatin enrichment
procedure. We defined a high-quality reference set of mito-
chondrial proteins and used this to train a machine-learning
algorithm to spot other mitochondrial proteins in our chro-
matin dataset. The results agreed well with the current con-
sensus of which proteins are in mitochondria. We could not
expect to obtain a comprehensive mitochondrial protein in-
ventory, because only⅓ of the knownmitochondrial proteins
were detected in our chromatin samples.However, this proof-
of-principle experiment demonstrates the possibility that tar-
geted biochemical enrichment may be optional and not es-
sential for defining organelles. Subcellular localization may
be predicted through covariation, thus allowing targeting a
structure during data analysis rather than experimentally.
C© 2015 The Authors. Proteomics Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
Proteomics 2016, 16, 393–401 395
2 Materials and methods
2.1 Chromatin proteomics data
Proteomic analyses of interphase chromatin were described
previously [11]. For this project we only considered 45 SILAC
ratios comparing chromatin under different biological con-
ditions. Only those 4565 proteins with values in at least ten
out of all 45 chromatin proteomics experiments were consid-
ered (Supporting Information Table 1). In brief, these experi-
ments consisted of human cell lines grown in SILACmedium
and subjected to various perturbations, such as treatment
with drugs, growth factors, or irradiation. They also include
SILAC-based comparisons of different cell types and cell-cycle
phases. In order to preferentially detect chromatin-boundpro-
teins, all samples were subjected to the chromatin enrich-
ment for proteomics (ChEP) procedure [13]. Tryptic digests
were analyzed by LC-MS/MS on an LTQ-Orbitrap or LTQ-
Orbitrap Velos (Thermo Fisher Scientific). These samples are
described as “biological classifier” experiments in Table 1 of
Kustatscher et al. [11] in more detail. Raw data have been de-
posited in the PRIDE [14] repository (www.ebi.ac.uk/pride)
as part of the dataset PXD000493 (for this study we only
used a subset of these data, namely experiments 3–7 and
18–35).
2.2 High-confidence mitochondrial reference protein
set
We compiled a set of well-studied, high-confidence mito-
chondrial reference proteins. As a starting point, we down-
loaded all 1065 human proteins that mapped to “mitochon-
drion” in Uniprot’s [15] subcellular localization database
(www.uniprot.org/locations) and that were part of Swiss-Prot.
We kept only proteins with an annotation score of at least
four out of five. To remove proteins with ambiguous local-
ization we filtered out proteins whose localization annotation
matched the following keywords: nucleus, reticulum, Golgi,
secreted, cytosol, peroxisome, and cell projection. This short-
listed 653 proteins, for which we manually evaluated Uniprot
and GO [16] annotations and, where necessary, searched the
available literature to extract a final list of 486 bona fide mi-
tochondrial proteins with no reported functions elsewhere
in the cell. Of these 486 mitochondrial reference proteins,
172 (35%) were detected in the chromatin proteomics dataset
(Supporting Information Table 2).
2.3 Random Forest prediction of mitochondrial
proteins
For supervised machine learning we used the Weka 3.7 [17]
implementation of the Random Forest algorithm [18], exe-
cuted through an in-house workflow built on the KNIME
data analytics platform [19]. This implementation of Random
Forest does not impute missing values. The Random For-
est was constructed using 500 trees, six random features at
each split and an unlimited maximum tree depth. The high-
confidence mitochondrial reference protein set was used as
positive training data. Negative training data were randomly
selected fromall nonmitochondrial proteins in our chromatin
proteomics dataset (for this purpose, nonmitochondrial was
defined as having no such annotation in GO or Uniprot).
To avoid using unbalanced training data, only 172 negative
training instances were selected, i.e. the same number as
positive training instances. However, rather than construct-
ing just one Random Forest, the workflow was executed ten
times with different randomly drawn negative training data.
The average Random Forest scores and their standard devia-
tion were collected. Prediction accuracy was assessed in two
different ways. The out-of-bag error, an unbiased estimate
of the test set error inbuilt to the algorithm, was collected.
In addition, the training dataset was cross-validated 100-fold,
and the cross-validated data were used to judge performance
based on the area under a ROC curve. Random Forest scores,
including the cross-validated scores for the mitochondrial
training dataset, are reported in the Supporting Information
Table 2.
2.4 Comparison with other mitochondrial datasets
We compared our mitochondrial predictions to five differ-
ent sources of mitochondrial annotation. The human ver-
sion of MitoCarta [20] was downloaded on May 1, 2015
from www.broadinstitute.org/pubs/MitoCarta. GO annota-
tions [16] were downloaded from QuickGO [21] using the
identifier “mitochondrion” (GO:0005739), restricted to the
qualifiers “contributes to,” “colocalizes with” and “none”.
Only annotations with evidence level “manual experimental”
were considered. The third externalmitochondrial protein set
consisted of proteins annotated as mitochondrial in Uniprot
and was downloaded as described for the high-confidence
mitochondrial reference protein set, without filtering against
multiple localizations. An immunofluorescence-based list of
proteins with mitochondrial localization was retrieved from
the Human Protein Atlas [22], omitting proteins with “uncer-
tain” reliability status. The fifth reference set consisted of mi-
tochondrial matrix proteins identified via spatially restricted
enzymatic tagging and MS [23].
2.5 Further data processing and visualization
Data were processed using R version 3.2 [24]. ID conversions,
where necessary, were done using Bioconductor biomaRt
package [25]. ROC curves were generated and visualized us-
ing ROCR R package [26]. Data analysis plots were prepared
using ggplot2 R package [27].
C© 2015 The Authors. Proteomics Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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3 Results and discussion
Covariation proved to be a successful concept in defining core
proteins of mitotic and interphase chromatin when starting
from multiple but impure proteomic lists of these struc-
tures [10, 11]. To test if this approach could be expanded
to structures that have not been the target of experimen-
tal data collection we attempted here to define mitochondria
through their coappearance in chromatin analyses. We chose
mitochondria for this proof-of-principle experiment, because
this organelle has been well-defined through other studies
and thus allows us to evaluate the success of our approach.
Mitochondria are membrane-enclosed and thus presumably
clearly defined, and their composition has been studied for
decades with many different experimental approaches, in-
cluding proteomics. This makes them a good reference point
to assess the performance of novel organelle proteomics ap-
proaches. Moreover, mitochondria contain more than thou-
sand proteins [20], several hundred of which are detected in
our chromatin samples, providing a reasonably sized test set
for our setup. It should be noted that somemitochondrial pro-
teins, such as prohibitins, have genuine additional functions
as nuclear transcription factors and so would be expected to
be found in chromatin [28]. However, the majority of mito-
chondrial proteins in our assay likely become associated with
chromatin in an artificial way at some point during chro-
matin enrichment, i.e. they are likely contaminants in our
chromatin analysis.
3.1 Biological perturbations affect the abundance of
mitochondrial proteins in chromatin samples
We observed that the presence of mitochondria in chro-
matin samples tends to change—very gently—in response
to biological perturbations (Fig. 1). This is initially counter-
intuitive as one would expect from a contaminating protein
that its presence would be largely unaffected by biologi-
cal changes in chromatin. Surprisingly, mitochondrial pro-
teins become mildly but significantly depleted (p = 1.13 ×
10–10) in chromatin samples after treating cells with TNFɑ
(Fig. 1A), they are more abundant (p = 7.26 × 10–22) in chro-
matin samples from HepG2 than HEK293 cells (Fig. 1B)
and they are depleted (p = 7.95 × 10–30) from chromatin
following 4-hydroxytamoxifen treatment (Fig. 1C). Indeed,
in most comparative chromatin proteomics experiments, we
find thatmitochondria are slightly enriched or depleted in one
condition compared to the other (Supporting Information
Table 3). These changes are likely due to the primary or sec-
ondary effects of a perturbation on the cell, although we can
only speculate about the precise mechanisms involved. For
example, alterations in chromatin structuremay affect the as-
sociation of background proteins, leading to increased or de-
creased copurification ofmitochondria with chromatin under
different conditions. In addition, the number ofmitochondria
per cell may also be altered in some experiments, e.g. when
comparing different cell types. While it is difficult to pinpoint
the exact reasons for mitochondrial abundance variation in
chromatin samples, we set out to test whether these changes
can be exploited to study mitochondrial proteins.
3.2 Mitochondria are not major contaminants in
chromatin samples
To ensure that mitochondria are a valid initial test system
for our method, we first confirmed that mitochondria are not
preferentially coenrichedwith chromatin. First, we noted that
mitochondrial proteins are nearly an order of magnitude less
abundant than chromatin proteins in these samples (Fig. 1D).
To further confirm their status as contaminants, we turned to
our chromatin proteome study, in which we assigned prob-
abilities for genuine chromatin-based functions to human
proteins. As expected, the vast majority of mitochondrial pro-
teins (94%) are not predicted to have a functional association
with chromatin (Supporting Information Fig. 1A). Finally, we
tested how mitochondrial abundance in chromatin samples
compares to that of various other organelles and common
contaminants, such as ribosomes, the cytoskeleton and the
Golgi apparatus. In fact, mitochondria are the least abundant
of the tested chromatin contaminants (Supporting Informa-
tion Fig. 1B).
3.3 Covariation in chromatin samples can predict
mitochondrial proteins
We previously observed coordinated bulk behavior for chro-
matin proteins versus background proteins across various bi-
ological situations [11]. This covariation of chromatin factors
allowed us to construct a comprehensive inventory of inter-
phase chromatin. We defined a reference set of known chro-
matin factors and then used a Random Forest machine learn-
ing algorithm to identify proteinswith similar behavior across
various chromatin proteomics experiments. Now, we tested
whether this approach could also capture a mitochondria-
specific pattern across the same set of chromatin proteomics
experiments.
We first assembled a high-confidence set of mitochondrial
proteins. We started from a list of proteins annotated asmito-
chondrial in Uniprot and removed all entries with potentially
ambiguous subcellular localization, such as mitochondrial
proteins with additional reported functions in the endoplas-
mic reticulum or elsewhere in the cell. For this we considered
information from Uniprot, GO, and the primary literature.
We further removed proteins which were generally not well
characterized, and could therefore not be considered bona
fide mitochondrial proteins. Of the remaining 486 proteins
we observed 172 (35%) in our data. We also sought to define
a high-confidence set of nonmitochondrial proteins without
introducing a bias. Such a bias could result from simply
C© 2015 The Authors. Proteomics Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Figure 1. Mitochondrial proteins in interphase chromatin samples. (A–C) Mitochondrial proteins (magenta) are present in chromatin
proteomics data, and are up- or downregulated in response to biological perturbations. For example, they are downregulated after treating
HeLa cells for 10 min with TNF compared to untreated controls (A). They are upregulated in chromatin samples purified from HepG2
as opposed to HEK293 cells (B). Mitochondria are also depleted from chromatin samples after treating estradiol-treated MCF7 cells with
4-hydroxytamoxifen (4-OHT) (C). The fold change is the SILAC ratio and protein abundance is the sum of measured peptide intensities.
The significance of mitochondrial fold-changes was evaluated by t-test and yielded p-values < 0.001 in all three cases, as illustrated by
the triple asterisks. (D) Boxplot of protein abundances showing that chromatin proteins are nearly an order of magnitude more abundant
than mitochondrial (Mitochon.) proteins, supporting the contaminant status of the latter. The sum of protein intensities measured across
all experiments is plotted. The intensity difference is highly significant according to a t-test (p-value = 5.4 × 10–32).
selecting nuclear proteins, for example. We solved this by
drawing nonmitochondrial proteins randomly from all pro-
teins in our dataset, except from proteins that had mitochon-
drial annotations in either Uniprot or GO.
We then conducted a supervised machine learning
experiment based on the Random Forest algorithm [18] to
distinguish mitochondrial from nonmitochondrial proteins
using a publically available chromatin proteomics dataset
(ProteomeXchange PXD000493) [11]. The dataset was
obtained by analyzing chromatin-enriched samples from
human cell lines grown in SILAC medium and subjected to
various perturbations, such as treatment with drugs, growth
factors, or irradiation. They also include SILAC-based com-
parisons of different cell types and cell-cycle phases. In order
to preferentially detect chromatin-boundproteins, all samples
were subjected to the ChEP procedure [13]. The chromatin
dataset comprised 23 double- and triple-SILAC experiments
with 45 SILAC ratios in total (Supporting Information
Table 1). The Random Forest was trained using the reference
sets ofmitochondrial and nonmitochondrial proteins. For the
nonmitochondrial training set to be representative of most
nonmitochondrial cellular compartments we would have had
to use significantly more than 172 proteins, as we used for
the mitochondrial training set. However, using unbalanced
training data skews the resulting scores. We therefore opted
to train ten Random Forests, each time with the same 172
mitochondrial proteins but a different set of 172 randomly
chosen nonmitochondrial training proteins. We collected
the average Random Forest scores for each protein. This
approach has the advantage of using a balanced training set
and still sample a large fraction of all nonmitochondrial pro-
teins to minimize prediction bias. In addition, the standard
deviation of the score across the ten different Random Forest
models reveals the impact of the choice of nonmitochondrial
training proteins. The resulting set of Random Forests could
distinguish between the known mitochondrial and nonmi-
tochondrial training proteins very well, as indicated by the
mean out-of-bag error of 0.1 ± 0.008. This shows that we can
identify mitochondrial proteins only based on their SILAC
ratios across many chromatin proteomics experiments.
We next performed 100-fold cross-validation to determine
reliable prediction scores for our high-confidence mitochon-
drial proteins. This means we constructed 100 Random
Forests and in each left out a different 1% of the reference
data, using the model generated with the remaining 99% to
obtain unbiased prediction scores for these proteins. This
allowed us to use a ROC curve to estimate the model’s per-
formance, in addition to the inbuilt out-of-bag error estimate
of the Random Forest algorithm. The mean area under the
ROC curve we obtained was 0.96 (Fig. 2A). This confirms the
high accuracy of our prediction already indicated by the low
out-of-bag error.
In addition to our reference mitochondrial proteins, many
other proteins with known mitochondrial functions received
high Random Forest scores (Fig. 2B). To evaluate our pre-
diction accuracy in a systematic way, we searched for false
positive predictions among our top hits. For this wemanually
assessed the available literature and labeled proteins as false
positives if they were well-characterized but lacked evidence
for mitochondrial localization. At a Random Forest score cut-
off of 0.69 we had 169 proteins of which 18 were clearly not
mitochondrial (10% false positives). Of the remaining 151
proteins (Fig. 2B), 94 are part of our high-confidence mito-
chondrial protein set and an additional 51 proteins are known
to bemitochondrial. Six proteins were poorly or ambiguously
annotated. For example, the prolyl hydroxylase LEPRE1 has
C© 2015 The Authors. Proteomics Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Figure 2. A Random Forest model can predict mitochondrial proteins based on their covariation in chromatin proteomics data. (A) High
accuracy of mitochondrial prediction is shown by ROC curves derived from the 100-fold cross-validated mitochondrial and nonmito-
chondrial reference set. The ten curves correspond to ten Random Forests generated with different negative training data, highlighting
the robustness of the Random Forest model. AUC: area under the curve. (B) Random Forest scores for the 4565 proteins (gray) in our
analysis. High-confidence mitochondrial reference proteins (magenta) are heavily enriched toward higher scores. The pie-chart shows the
manual annotation of proteins within the dashed rectangle, corresponding to a score cut-off of 0.69. Most proteins are either part of our
high-confidence mitochondrial reference set or other known mitochondrial proteins. Six proteins were poorly annotated. 18 proteins were
classified as nonmitochondrial, i.e. they are well-annotated but no evidence for mitochondrial function exists. This group was used to
estimate that we have about 10% false positives at this score cut-off.
one isoform that is thought to be secreted [29] and another one
that may reside in mitochondria [30], but our data do not al-
low us to distinguish between the two. The other five proteins
are candidates for novel mitochondrial proteins, warranting
further study into their biological function.
3.4 Mitochondria predictions agree well with
established mitochondrial protein inventories
To determine the specificity and sensitivity of our approach
in more detail, we compared its predictions to existing mito-
chondrial annotation data (Fig. 3). The most comprehensive
inventory ofmitochondrial proteins yet,MitoCarta, combined
proteomic analysis of isolated mitochondria with GFP tag-
ging and microscopy, and included additional genome-scale
datasets such as the occurrence ofmitochondrial targeting se-
quences [20]. The vast majority of proteins that receive high
mitochondrial scores in our study are indeed found in Mi-
toCarta, confirming the high specificity of our predictions
(Fig. 3A). There is also strong enrichment of MitoCarta pro-
teins toward high RandomForest scores. However, a number
of MitoCarta proteins do not score high in our approach, rais-
ing the possibility that “prediction by covariation” may lack
sensitivity. Alternatively, low-scoring proteins in our model
may have been falsely assigned to mitochondria by classical
proteomic approaches, for example due to an artificial copu-
rification with mitochondria-enriched biochemical fractions.
To test this possibility, we followed three separate lines of
evidence.
First, we compared MitoCarta’s confidence measure, the
Maestro score, to our Random Forest score. MitoCarta en-
tries which scored low in our analysis also tend to have been
assigned to MitoCarta with lower confidence (Supporting In-
formation Fig. 2). Next, we compared our predictions to a
second, independent proteomic dataset that targeted proteins
of the mitochondrial matrix rather than the entire mitochon-
drion [23]. In this approach, a geneticallymodified peroxidase
enzyme is fused to a localization signal that specifically targets
it to the mitochondrial matrix, where it biotinylates proteins
in close physical proximity. This method results in very high
specificity, because the inner mitochondrial membrane acts
as a barrier confining the biotin label tomatrix proteins. Inter-
estingly, when compared to our Random Forest predictions,
there are far fewer low-scoring proteins amongmitochondrial
factors identified in this way (Fig. 3B). This is also exempli-
fied by a shift of median Random Forest score from 0.60 for
MitoCarta proteins to 0.76 for mitochondrial proteins listed
by Rhee et al. [23].
For a third specificity test, we compiled a consensus list of
mitochondrial proteins by integrating four subcellular local-
ization databases: MitoCarta, Uniprot, GO, and the Human
Protein Atlas [15, 16, 20, 22]. There was complete agreement
among the four databases on 245 proteins. One hundred
forty-three of these we observed in our study. Similar to
the matrix annotations from Rhee et al. [23], we find that
the vast majority of these 143 consensus proteins rank very
C© 2015 The Authors. Proteomics Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Figure 3. Covariation-based prediction evaluated by comparison to existingmitochondrial protein inventories. (A) Mitochondrial prediction
for all 4565 proteins is shown as their Random Forest machine learning score. Proteins that are present in MitoCarta [20] are highlighted in
orange. There is a strong enrichment ofMitoCarta proteins toward high Random Forest scores (see bar chart). (B) Same plot but highlighting
proteins in green that were specifically assigned to the mitochondrial matrix by Rhee et al. [23]. Note that very few of these annotations
receive low Random Forest scores. Many high scoring proteins are mitochondrial but not in Rhee et al.’s [23] matrix proteome. (C) Proteins
in magenta are annotated as mitochondrial in four different databases: MitoCarta, Uniprot, GO, and the Human Protein Atlas (HPA). These
overlapping, high-confidence annotations include fewer low-scoring predictions than proteins found in only 1, 2, or 3 of these databases
(see bar chart). (D) Distribution of mean Random Forest scores for proteins annotated as mitochondrial in either of the four indicated
databases. Individually, all databases show a bimodal distribution. Restricting the analysis to the overlapping annotations shows a marked
reduction in low-scoring annotations (see arrow). This indicates that such proteins are not just missed in our prediction due to lack of
sensitivity, but are also not supported by other databases. (E) Venn diagram depicting the overlap of mitochondrial annotations in the four
databases, including proteins not detected in our dataset.
high in our predictions (median Random Forest score 0.74)
(Fig. 3C). Interestingly, any individual database contains a
number of mitochondrial annotations that receive low scores
in our assay (Fig. 3D). Increasing the number of databases
that must agree on a protein to be mitochondrial decreases
the number of low scoring annotations and improves the
median Random Forest score (any database: 0.27, any two
databases 0.46, any three databases: 0.63, all four databases:
0.74).
These three points suggest that our Random Forest anal-
ysis succeeds in recognizing bona fide components of mito-
chondria. Scoring low in our analysis indicates that a protein
is less likely to be a genuine component of mitochondria.
A conclusive evaluation of false negatives in our analysis is
complicated by an absence of large consensus on mitochon-
drial proteins. A total of 1798 proteins are labeled “mitochon-
drial” by at least one database while the four databases agree
on only 245 (Fig. 3E). However, two reasons could account
for genuine mitochondrial proteins scoring low in our as-
say. First, the accuracy of the Random Forest classification
depends on the number of experiments available to it, so in-
creasing the number of input experiments will increase per-
formance further. Also, we cannot expect to identify “condi-
tional”mitochondrial factors, i.e. proteins that only localize to
mitochondria under certain biological conditions. This is be-
cause such proteins may have a predominant function else-
where in the cell and therefore not covary with mitochondrial
reference proteins.
Due to the low coverage of mitochondrial proteins in the
chromatin dataset, we are unable to make predictions on
the majority of the estimated 1129 mitochondrial proteins
[20]. For example, we detected 389 (38%) of the 1013 pro-
teins in human MitoCarta. Therefore, we cannot carry out
a comprehensive analysis of the entire organelle and cannot
match existing resources likeMitoCarta in terms of complete-
ness. Most published proteomics data now become available
through repositories such as PRIDE, so we expect that in
the future it will be possible to mine much larger datasets
for mitochondrial proteins in this way. While we only show
here the example of mitochondria in chromatin samples, we
would expect that, in principle, any comparative proteomics
experiment could be used as input dataset, as long as some
components of the target structure have been detected and
accurately quantified in it. It should be noted that with this
method no individual experiment needs to strongly separate
the target structure from the rest of the cell, but separation is
achieved by integrating many small, apparently insignificant
differences into one machine learning score.
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3.5 Feature count influences prediction accuracy
One important parameter affecting the accuracy ofmitochon-
drial predictions by machine learning is the “feature count,”
i.e. the number of different experiments in which a protein
was quantified. The more feature counts (SILAC ratios) are
available to establish the “covariation pattern” of a protein,
the better a protein can be assigned to a certain functional
group. For example, some of the 143 mitochondrial consen-
sus proteins, onwhich all annotation databases agree, remain
below our mitochondrial prediction cut-off. These mitochon-
drial proteins have been quantified in a median of 16 ± 7
SILAC experiments. By contrast, the consensus proteins that
score above cut-off and are thus successfully predicted to be
mitochondrial, have a median of 22 ± 9 features, and this
difference is statistically significant (p-value < 0.001).
Ourmitochondrial protein predictions are based on SILAC
data, i.e. relative rather than absolute protein abundances.
This implies that protein abundance itself should not have
a direct impact on prediction accuracy, but there is arguably
an indirect effect of protein abundance on performance. For
example, abundant proteins will generally be observed more
often, resulting in higher feature counts. SILAC quantitation
itself also tends to be more accurate for abundant proteins.
3.6 Implications for the design of SILAC studies
The observation that background in SILAC experiments
changes systematically has implications for the design of
comparative proteomics studies. For example, studies that
test the effect of a drug on chromatin proteins would typi-
cally compare chromatin fractions from treated samples with
a mock control and may conclude that all measured changes
relate to the drug’s effect on chromatin composition. How-
ever, our observations suggest that care should be takenwhen
drawing such conclusions. Changes among the purification
background, either through direct or indirect effects of the
perturbation, are in fact widespread. This is illustrated by the
fact that mitochondria can be up- and downregulated signif-
icantly in chromatin samples between experiment and con-
trol (Fig. 1A–C). We made a similar observation in a screen
for novel DNA replication factors, where we isolated nascent
chromatin using an unrelated biochemical procedure [31].
Upon comparing nascent andmature chromatin we observed
many differences that were clearly unrelated to chromatin
replication. These rather reflected alterations in chromatin as-
sociation of background proteins. To obtain high-confidence
DNA replication factors we filtered the data using interphase
chromatin probabilities [11].
4 Concluding remarks
We provide proof-of-principle data to show that background
in comparative proteomics experiments is not static or
random, but exhibits fluctuations that are possibly biologi-
cally meaningful and can, in fact, be exploited. Background
proteins with similar functions, such as mitochondrial fac-
tors, are coordinately up- or downregulated in chromatin anal-
yses. We demonstrate that this makes it possible to predict
components of mitochondria based solely on their behavior
in chromatin samples, by quantifying their presence across
a diverse range of conditions and using machine learning to
compare it to reference proteins of known function. In prin-
ciple, we would expect our approach to work for any organelle
or compartment that has been detected in quantitative pro-
teomics data although this remains to be demonstrated. With
specific significance to nuclei, a large number of nuclear bod-
ies have been difficult to purify on their own and may well
be seen as “shadows” in our chromatin data. Future work
will have to show if shadow proteomics provides a path to
mapping these and other elusive structures in cells.
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